Guangzhou Kingmed Diagnostics Group Co Ltd Strategic Asset Allocation Index
Guangzhou Kingmed Diagnostics Group Co Ltd strategic asset allocation index. Guangzhou Kingmed Diagnostics Group Co Ltd (603882) has a Strategic Asset Allocation Index of 28.3% as of June 2023. Strategic assets (PP&E of CN¥2.37 Billion plus long-term investments of CN¥-) total CN¥2.37 Billion, measured against net assets of CN¥8.37 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 603882 equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guangzhou Kingmed Diagnostics Group Co Ltd (2012–2022)
Strategic asset allocation index of Guangzhou Kingmed Diagnostics Group Co Ltd from 2012 to 2022. This chart shows how Guangzhou Kingmed Diagnostics Group Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 28.3%, representing strategic assets of CN¥2.37 Billion against net assets of CN¥8.37 Billion CNY. Check Guangzhou Kingmed Diagnostics Group Co L tangible equity quality to evaluate the tangible quality of the company's equity base.
Guangzhou Kingmed Diagnostics Group Co Ltd Strategic Asset Allocation Index by Year (2012–2022)
Guangzhou Kingmed Diagnostics Group Co Ltd strategic asset allocation index by year from 2012 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Kingmed Diagnostics Group Co Ltd from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Guangzhou Kingmed Diagnostics Group Co L market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 25.0% | CN¥2.22 Billion | CN¥2.22 Billion | CN¥- | CN¥8.87 Billion | ▼ -5.2 pp |
| 2021 | 30.2% | CN¥1.97 Billion | CN¥1.97 Billion | CN¥- | CN¥6.52 Billion | ▼ -1.4 pp |
| 2020 | 31.6% | CN¥1.22 Billion | CN¥1.22 Billion | CN¥- | CN¥3.88 Billion | ▼ -15.3 pp |
| 2019 | 46.9% | CN¥1.09 Billion | CN¥1.09 Billion | CN¥- | CN¥2.33 Billion | ▼ -12.5 pp |
| 2018 | 59.4% | CN¥1.16 Billion | CN¥1.16 Billion | CN¥- | CN¥1.96 Billion | ▼ -5.4 pp |
| 2017 | 64.8% | CN¥1.13 Billion | CN¥1.13 Billion | CN¥- | CN¥1.74 Billion | ▼ -18.9 pp |
| 2016 | 83.7% | CN¥949.09 Million | CN¥949.09 Million | CN¥- | CN¥1.13 Billion | ▲ +1.5 pp |
| 2015 | 82.2% | CN¥788.95 Million | CN¥788.95 Million | CN¥- | CN¥959.84 Million | ▲ +32.8 pp |
| 2014 | 49.4% | CN¥193.66 Million | CN¥193.66 Million | CN¥- | CN¥391.72 Million | ▼ -7.5 pp |
| 2013 | 56.9% | CN¥147.12 Million | CN¥147.12 Million | CN¥- | CN¥258.41 Million | ▲ +4.9 pp |
| 2012 | 52.1% | CN¥106.07 Million | CN¥106.07 Million | CN¥- | CN¥203.69 Million | — |